Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Innovative Technique for Coronary Angiography in Marginal Donors
Published on: July 12, 2024
[Evolution of contrast nephropathy in patients with chronic kidney disease undergoing a percutaneous coronary
Bibiana López-López1, María Juana Pérez-López, Andrés García-Rincón
1Hospital de Especialidades Centro Médico Nacional La Raza,Instituto Mexicano del Seguro Social, Distrito Federal, México. dra-bibi@hotmail.com.
Insights
Contrast-induced nephropathy (CIN) occurred in 6.3% of high-risk chronic kidney disease patients undergoing percutaneous coronary intervention, despite preventive measures. Early nephrology assessment may reduce CIN frequency in these vulnerable patients.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- The global shift towards chronic-degenerative diseases increases demand for contrast-enhanced procedures.
- Contrast media pose a significant risk for acute kidney injury, especially in patients with chronic kidney disease (CKD).
Purpose of the Study:
- To determine the incidence and progression of contrast-induced nephropathy (CIN) in ambulatory CKD patients undergoing percutaneous coronary intervention (PCI).
Main Methods:
- A cohort of 32 CKD patients undergoing cardiac catheterization were monitored post-procedure.
- Patients received preventive measures, and creatinine levels were assessed at 48 hours.
- Descriptive statistics were used for analysis.
Main Results:
- Of 1236 procedures, 32 met inclusion criteria; 96.87% had comorbidities like diabetes or hypertension.
- 6.3% of patients developed CIN (creatinine >25% increase at 48 hours) despite prophylaxis.
- No patients required renal replacement therapy.
Conclusions:
- CIN incidence in high-risk CKD patients was lower than literature reports.
- Pre-procedure nephrology assessment may contribute to reduced CIN rates.
Introduction:
Current epidemiological transition from infectious to chronic-degenerative diseases is more and more demanding procedures requiring contrast medium, which turns out to be a risk factor for acute renal major damage in patients with chronic kidney disease. The aim of this article is to describe the frequency and evolution of Contrast-induced nephropathy in ambulatory patients with chronic kidney disease undergoing percutaneous coronary intervention.
Methods:
We included patients with renal damage at the time of exposure to the contrast medium. They took a risk and were adjusted prevention measures follow at 48 hrs. Statistical analysis was performed using descriptive statistics.
Results:
From 1236 cardiac catheterization procedure performed, 32 patients met the inclusion criteria. The 96.87% had chronic degenerative diseases such as diabetes or hypertension, overweight and obesity were a constant in 65.62% of cases, in 21.7% of patients the contrast dose was slightly higher than recommended. The 6.3% developed contrast-induced nephropathy with elevated creatinine greater than 25% at 48 hours after the procedure, despite preventive measures, however none of them required renal replacement.
Conclusions:
The frequency of contrast medium-induced nephropathy in patients with high risk factors was lower than that reported in the literature; this may correspond to that in all cases nephrology assessment was performed before the procedure.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology

